Venetoclax dose-escalation and obinutuzumab treatment schedule in a clinical trial
Deborah Sims is a young chronic lymphocytic leukaemia (CLL) patient, undertaking a clinical trial of obinutuzumab and venetoclax (ABT-199). Here, Deborah describes the dose-escalation regime of venetoclax and how it fits with the obinutuzumab treatment schedule. At this point, Deborah has done the first round of obinutuzumab.
To learn more about Deborah's story visit her blog at abtandme.com
Visit our website | http://www.patientpower.eu/
Follow on Twitter | https://twitter.com/patientpowereu
Like on Facebook | https://www.fb.com/patientpower.europe
Видео Venetoclax dose-escalation and obinutuzumab treatment schedule in a clinical trial канала Patient Power Europe
To learn more about Deborah's story visit her blog at abtandme.com
Visit our website | http://www.patientpower.eu/
Follow on Twitter | https://twitter.com/patientpowereu
Like on Facebook | https://www.fb.com/patientpower.europe
Видео Venetoclax dose-escalation and obinutuzumab treatment schedule in a clinical trial канала Patient Power Europe
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![¿Cómo puede saber el paciente cuál es su mejor opción de tratamiento?](https://i.ytimg.com/vi/LFHqDWlb8vI/default.jpg)
![L’accès à l’information médicale de qualité](https://i.ytimg.com/vi/RKQVm-jsa-M/default.jpg)
![Mensaje para los argentinos afectados por cánceres hematológicos](https://i.ytimg.com/vi/zQ6Mc5FmEeI/default.jpg)
![Prof Michele Cavo’s take-home message for patients from the Myeloma 2015 meeting](https://i.ytimg.com/vi/ffohCqJJ8Fo/default.jpg)
![Wie wird eine CLL diagnostiziert und welche Rolle spielen Mutationen bei der Therapiewahl?](https://i.ytimg.com/vi/36xLw4H-Zyw/default.jpg)
![Prof. Dr. Stephan Stilgenbauer über neue Behandlungsmöglichkeiten bei CLL](https://i.ytimg.com/vi/P0qDV8ad_is/default.jpg)
![Empfehlungen für Patienten mit AML](https://i.ytimg.com/vi/xTLtLZzkBHA/default.jpg)
![Dr. Andreas Mumm über die Rehabilitation beim Multiplem Myelom](https://i.ytimg.com/vi/wjzRnrlF2z0/default.jpg)
![Changing your lifestyle following treatment of acute myeloid leukaemia (AML)](https://i.ytimg.com/vi/noZep0nkkHw/default.jpg)
![Le associazioni dei pazienti affetti da neoplasia](https://i.ytimg.com/vi/jlpilHJNQn4/default.jpg)
![New breast cancer data from EBCC9: what does this mean for the patient?](https://i.ytimg.com/vi/H0dE5Tf6xTg/default.jpg)
![Cómo se diagnostica la leucemia linfática crónica](https://i.ytimg.com/vi/vysFhUbXRos/default.jpg)
![Prof. Dr. Stephan Stilgenbauer über die „Watch-and-wait“-Strategie bei asymptomatischer CLL](https://i.ytimg.com/vi/mQrLaB_4Yw8/default.jpg)
![Prof. Dr. Stilgenbauer über Durchbrüche in der Therapie der chronischen lymphatischen Leukämie](https://i.ytimg.com/vi/7tKVF--3IDg/default.jpg)
![Pregnancy in patients with myeloproliferative neoplasms](https://i.ytimg.com/vi/LOtlbj6oXaE/default.jpg)
![How to deal with the emotional stress following an acute leukaemia diagnosis](https://i.ytimg.com/vi/PbMoM8cD5Eo/default.jpg)
![Reduce your fatigue levels with physical activity](https://i.ytimg.com/vi/OIl2MgPyjQU/default.jpg)
![Chronische lymphatische Leukämie Highlights von ASH 2016](https://i.ytimg.com/vi/P0Tt96-Q6zY/default.jpg)
![Leukämie in Kindern - Unterstützung für die ganze Familie und Normalität](https://i.ytimg.com/vi/ArJ2o5Xz-Lk/default.jpg)
![ENRICH clinical trial for untreated mantle cell lymphoma](https://i.ytimg.com/vi/huUzoIO_0H8/default.jpg)